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Summary. Apoptosis (programmed cell death) is a 
genetically programmed active cell death process for 
maintaining homeostasis under physiological conditions 
and for responding to various stimuli. Many human 
diseases have been associated with either increased 
apoptosis (such as AIDS and neurodegenerative 
disorders) or decreased apoptosis (such as cancer and 
autoimmune disorders). In an attempt to understand 
apoptosis signaling pathway and genes associated with 
apoptosis, we established two cell model systems on 
which apoptosis is induced either by DNA damaging 
agent, etoposide or by redox agent, 1,lO-phenanthroline 
(OP). DNA chip profiling or mRNA differential display 
(DD) was utilized to identify genes responsive to 
apoptosis induced by these two agents. In etoposide 
model with chip hybridization, we defined signaling 
pathways that mediate apoptosis in p53 dependent 
manner (through activation of p53 target genes such as 
Waf-lIp21, PCNA, GPX, S100A2 and PTGF-S) as well 
as in p53-independent manner (through activation of 
ODC and TGF-S receptor, among others). In OP model 
with DD screening, we cloned and characterized two 
genes: glutathione synthetase, encoding an enzyme 
involved in glutathione synthesis and Sensitive to 
Apoptosis Gene (SAG), a novel evolutionarily conserved 
gene encoding a zinc RING finger protein. Both genes 
appear to protect cells from apoptosis induced by redox 
agents. Further characterization of SAG revealed that it 
is a growth essential gene in yeast and belongs to a 
newly identified gene family that promotes protein 
ubiquitination and degradation. Through this activity, 
SAG regulates cell cycle progression and many other key 
biological processes. Thus, SAG could be a valid drug 
target for anti-cancer and anti-inflammation therapies. 
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Apoptosis - a general introduction 
Apoptosis, also called programmed cell death, is a 
genetically programmed active process for maintaining 
homeostasis under physiological conditions and for 
responding to various internal and external stimuli 
(Vaux, 1993; Thompson, 1995). This form of cell death 
is characterized by cell membrane blebbing, cytoplasmic 
shrinkage, nuclear chromatin condensation and DNA 
fragmentation (Wyllie et al., 1980). Apoptosis occurs in 
both embryonic cells during development as well as 
differentiated cells in adult tissues. Apoptotic cells 
usually commit suicide for the greater good of the body. 
Many human diseases have been associated with altered 
apoptosis.  The  common diseases associated with 
increased apoptosis include AIDS, ischemic injuries 
(such as  myocardial infarction, strokes),  and 
neurodegenerative disorders (such as Alzheimer's or 
Parkinson's diseases, amyotrophic lateral sclerosis, 
retinitis pigmentosa, and cerebellar degeneration). 
Diseases associated with decreased apoptosis include 
cancers, autoimmune disorders and viral infections 
(Thompson, 1995). 
Apoptosis can be induced by a wide variety of 
physical, chemical and biological stimuli. They include 
ionizing radiation, UV, chemotherapeutic drugs that 
damage DNA, reactive oxygen species, cytokines and 
their receptors, and some oncogenes (myc, E1A) and 
tumor suppressor genes (p53), among others. On the 
other hand, apoptosis can be inhibited by some 
physiological inhibitors (such as  growth factors, 
extracellular matrix), several viral genes (ElB, p35) and 
some pharmacological agents (calpain inhibitors, 
cysteine protease inhibitors) (Thompson, 1995). 
The process of apoptosis can be divided into three 













